ARCHIVES

Second-Generation CML Drugs Show Promise For Frontline

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001

Diet-Nutrition Grant Guidelines: NIH Says They’re CREGS, Gori Says They’re Not

April 9, 1976

Interview with FDA’s Richard Pazdur

October 30, 2009

High Radiation Dose Effective Ten Years After Treatment

November 28, 2003

Organ Site Program Fate On Line, Gets Review Next Week

November 20, 1981

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014